NasdaqCM - Nasdaq Real Time Price • USD
Exact Sciences Corporation (EXAS)
At close: May 9 at 4:00 PM EDT
After hours: May 9 at 7:56 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,534,840.00
2,499,766.00
2,084,279.00
1,767,087.00
1,491,391.00
Cost of Revenue
667,400.00
654,200.00
574,400.00
458,757.00
354,300.00
Gross Profit
1,867,440.00
1,845,566.00
1,509,879.00
1,308,330.00
1,137,091.00
Operating Expense
2,106,955.00
2,059,915.00
2,087,412.00
2,143,798.00
1,695,104.00
Operating Income
-239,515.00
-214,349.00
-577,533.00
-835,468.00
-558,013.00
Net Non Operating Interest Income Expense
-41,821.00
-29,771.00
-19,634.00
-18,606.00
-17,122.00
Other Income Expense
43,762.00
42,416.00
-35,394.00
11,568.00
-253,911.00
Pretax Income
-237,674.00
-201,746.00
-632,570.00
-842,506.00
-829,063.00
Tax Provision
2,552.00
2,403.00
-9,064.00
-246,881.00
-5,458.00
Net Income Common Stockholders
-240,226.00
-204,149.00
-623,506.00
-595,625.00
-823,605.00
Diluted NI Available to Com Stockholders
-240,226.00
-204,149.00
-623,506.00
-595,625.00
-823,605.00
Basic EPS
-1.31
-1.13
-3.54
-3.48
-5.45
Diluted EPS
-1.31
-1.13
-3.54
-3.48
-5.45
Basic Average Shares
181,088.00
180,144.00
176,351.00
171,348.00
151,137.00
Diluted Average Shares
181,088.00
180,144.00
176,351.00
171,348.00
151,137.00
Total Operating Income as Reported
-244,613.00
-215,012.00
-593,511.00
-855,678.00
-767,696.00
Total Expenses
2,774,355.00
2,714,115.00
2,661,812.00
2,602,555.00
2,049,404.00
Net Income from Continuing & Discontinued Operation
-240,226.00
-204,149.00
-623,506.00
-595,625.00
-823,605.00
Normalized Income
-266,483.20
-237,657.64
-588,572.12
-603,803.58
-571,217.47
Interest Expense
--
24,421.00
13,907.00
12,879.00
11,819.00
Net Interest Income
-41,821.00
-29,771.00
-19,634.00
-18,606.00
-17,122.00
EBIT
-200,707.00
-177,325.00
-618,663.00
-829,627.00
-817,244.00
EBITDA
10,101.00
29,283.00
-421,105.00
-649,281.00
-653,882.00
Reconciled Cost of Revenue
549,135.00
539,752.00
474,292.00
373,412.00
284,336.00
Reconciled Depreciation
210,808.00
206,608.00
197,558.00
180,346.00
163,362.00
Net Income from Continuing Operation Net Minority Interest
-240,226.00
-204,149.00
-623,506.00
-595,625.00
-823,605.00
Total Unusual Items Excluding Goodwill
43,762.00
42,416.00
-35,394.00
11,568.00
-253,911.00
Total Unusual Items
43,762.00
42,416.00
-35,394.00
11,568.00
-253,911.00
Normalized EBITDA
-33,661.00
-13,133.00
-385,711.00
-660,849.00
-399,971.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
17,504.80
8,907.36
-460.12
3,389.42
-1,523.47
12/31/2020 - 2/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GH Guardant Health, Inc.
19.44
+4.29%
ILMN Illumina, Inc.
111.35
+0.66%
TWST Twist Bioscience Corporation
43.20
+4.35%
NTRA Natera, Inc.
95.55
-0.11%
MYGN Myriad Genetics, Inc.
25.25
+5.43%
OPK OPKO Health, Inc.
1.2600
+0.80%
TMO Thermo Fisher Scientific Inc.
577.93
+0.75%
VCYT Veracyte, Inc.
20.63
+2.53%
WAT Waters Corporation
336.42
+3.90%
IDXX IDEXX Laboratories, Inc.
500.82
+2.82%